ClinicalTrials.govpublic full text
Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)
weight loss, metabolic syndrome, diabetes mellitus, type 2, central obesity, insulin resistance, glucose intolerance
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 184768
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.